Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Procedural Learning in Participants With ADHD

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2007 by Shaare Zedek Medical Center.
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
Shaare Zedek Medical Center
ClinicalTrials.gov Identifier:
NCT00446537
First received: March 11, 2007
Last updated: March 12, 2007
Last verified: January 2007
  Purpose
Skill acquisition refers to the process of improvement of performance following practice experience. This process is the basis for generation of a long-lasting memory. Individuals with Attention Deficit Hyperactivity Disorder (ADHD) have been shown to be impaired on some performance aspects of previously learned skills, an impairment that is often ameliorated, at least temporarily, by psychostimulant medication (the standard therapy in ADHD). The proposed study aims to define the course of learning and of generation of long-term memory consolidation in individuals with ADHD, and to essay the effectiveness of psychostimulant medication on both the learning and retention of the skills.

Condition Intervention Phase
Attention Deficit Hyperactivity Disorder
Procedure: Methylphenidate
Phase 0

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double-Blind

Resource links provided by NLM:


Further study details as provided by Shaare Zedek Medical Center:

Detailed Description:
Skill Acquisition and the Evolution of Long Term Procedural Memory in participants with ADHD: The Effect of Methylphenidate
  Eligibility

Ages Eligible for Study:   12 Years to 50 Years   (Child, Adult)
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Full scale IQ score of 85 or above
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00446537

Locations
Israel
Neuropediatric Unit
Jerusalem, Israel, 91031
Sponsors and Collaborators
Shaare Zedek Medical Center
Investigators
Principal Investigator: Esther Adi-Japha, PhD Bar-Ilan University, Israel
Study Chair: Ruth Shalev, MD Shaare Zedek Medial Center
  More Information

ClinicalTrials.gov Identifier: NCT00446537     History of Changes
Other Study ID Numbers: 240446 
Study First Received: March 11, 2007
Last Updated: March 12, 2007
Health Authority: Israel: Ethics Commission

Keywords provided by Shaare Zedek Medical Center:
Skill Acquisition and the Evolution of Long Term Procedural Memory in participants with ADHD: The Effect of Methylphenidate

Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity
Attention Deficit and Disruptive Behavior Disorders
Neurodevelopmental Disorders
Mental Disorders
Methylphenidate
Central Nervous System Stimulants
Physiological Effects of Drugs
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dopamine Agents
Neurotransmitter Agents

ClinicalTrials.gov processed this record on December 02, 2016